OZEM vs. IDNA ETF Comparison
Comparison of Roundhill GLP-1 & Weight Loss ETF (OZEM) to iShares Genomics Immunology and Healthcare ETF (IDNA)
OZEM
Roundhill GLP-1 & Weight Loss ETF
OZEM Description
OZEM targets the global weight management industry. The fund invests in companies involved in the development of GLP-1 and other weight loss drugs. GLP-1 agonists seek to aid in weight management by lowering blood sugar levels, reducing appetite, and promoting fullness. The portfolio consists of firms with GLP-1 and weight loss drugs that have been approved by or are currently undergoing Phase I, Phase II, and/or Phase III clinical trials of the US Food & Drug Administration (FDA), or any applicable food and drug regulator for non-US companies. The portfolio is constructed using a proprietary methodology, which selects companies with high levels of thematic relevance based on research of each companys public filings and disclosures. In addition, eligible securities must meet minimum market-cap and liquidity requirements. The actively managed fund, although rebalances portfolio weighting on at least a quarterly basis, may have a heavy concentration on a few names.
Grade (RS Rating)
Last Trade
$25.91
Average Daily Volume
37,536
14
IDNA
iShares Genomics Immunology and Healthcare ETF
IDNA Description
The investment seeks to track the investment results of the NYSE FactSet Global Genomics and Immuno Biopharma Index. The fund generally will invest at least 90% of its assets in the component securities of the index and in investments that have economic characteristics that are substantially identical to the component securities of the index and may invest up to 10% of its assets in certain futures, options and swap contracts, cash and cash equivalents. The index is composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology and bioengineering. It is non-diversified.Grade (RS Rating)
Last Trade
$23.66
Average Daily Volume
30,038
34
Performance
| Period | OZEM | IDNA |
|---|---|---|
| 30 Days | -7.33% | -1.43% |
| 60 Days | -7.73% | -3.01% |
| 90 Days | -10.10% | -5.37% |
| 12 Months | 19.24% |
1 Overlapping Holdings
| Symbol | Grade | Weight in OZEM | Weight in IDNA | Overlap | |
|---|---|---|---|---|---|
| REGN | F | 2.4% | 3.11% | 2.4% |
OZEM Underweight 33 Positions Relative to IDNA
| Symbol | Grade | Weight | |
|---|---|---|---|
| EXEL | B | -6.67% | |
| RVMD | C | -5.9% | |
| GILD | C | -5.81% | |
| BGNE | D | -5.16% | |
| INCY | C | -4.99% | |
| ACLX | C | -4.09% | |
| SRPT | D | -3.75% | |
| MRK | F | -3.2% | |
| SWTX | C | -2.8% | |
| TWST | D | -2.72% | |
| LGND | B | -2.4% | |
| GERN | D | -2.36% | |
| IOVA | F | -2.16% | |
| BEAM | D | -2.12% | |
| DVAX | C | -1.88% | |
| BCRX | D | -1.74% | |
| BPMC | C | -1.55% | |
| NRIX | D | -1.49% | |
| NVAX | F | -1.26% | |
| MRNA | F | -1.06% | |
| CRSP | D | -0.98% | |
| IBRX | C | -0.91% | |
| RCUS | F | -0.8% | |
| VIR | D | -0.72% | |
| ARCT | F | -0.49% | |
| OABI | F | -0.43% | |
| FDMT | F | -0.41% | |
| XNCR | B | -0.38% | |
| NTLA | F | -0.34% | |
| QURE | D | -0.33% | |
| DNA | F | -0.27% | |
| EDIT | F | -0.23% | |
| MGNX | F | -0.22% |
OZEM: Top Represented Industries & Keywords
IDNA: Top Represented Industries & Keywords
Compare ETFs
